Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company developing innovative cell therapies, primarily CAR T treatments for cancers and autoimmune diseases. Its pipeline includes therapies targeting glioblastoma, hematologic malignancies, and autoimmune conditions, often in partnership with leading research institutions. The company focuses on licensing advanced technologies, supporting clinical trials, and commercializing targeted immunotherapies to address unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.